English version of this page

Publikasjoner 2012

Listen inneholder publikasjoner fra Klinisk Effektforskningsgruppen ved Avdeling for Helseledelse og Helseøkonomi. I 2012 ble det utgitt 19 publikasjoner og kommentarer i fagfellevurderte tidsskrifter. 13 (68%) av disse ble publisert i gruppe 2 tidsskrifter og 5 (26%) i gruppe 2a. Kumulativ impact faktor for gruppens artikler i 2012 er 66.

Publikasjonsliste

Originalartikler:

1. Kalager M, Tamimi RM, Bretthauer M, Adami HO. Prognosis in women with interval breast cancer: population based observational cohort study. BMJ. 2012;345:e7536. PMID 23160783 Impact factor: 16.378

2. Valori R, Rey JF, Atkin WS, Bretthauer M, Senore C, Hoff G, Kuipers EJ, Altenhofen L, Lambert R, Minoli G. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy. 2012;44 Suppl 3:SE88-105. PMID 23012124
Impact factor: 5.196

3. Garborg KK, Løberg M, Matre J, Holme O, Kalager M, Hoff G, Bretthauer M. Reduced pain during screening colonoscopy with an ultrathin colonoscope: a randomized controlled trial. Endoscopy. 2012;44:740-6. PMID 22622786
Impact factor: 5.196

4. Moritz V, Bretthauer M, Ruud HK, Glomsaker T, de Lange T, Sandvei P, Huppertz-Hauss G, Kjellevold Ø, Hoff G. Withdrawal time as a quality indicator for colonoscopy - a nationwide analysis. Endoscopy. 2012;44:476-81. PMID 22531983
Impact factor: 5.196

5. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012 156:491-9. PMID 22473436
Impact factor: 16.104

6. Hoff G, Moritz V, Bretthauer M, Aabakken L, Berset IP, Glomsaker T, Høie O, de Lange T. Incontinence after colonoscopy--an unrecognized and preventable problem. A cross-sectional study from the Gastronet quality assurance program. Endoscopy. 2012;44:349-53. PMID 22392101
Impact factor: 5.196

7. Bretthauer M; in:European Colorectal Cancer Screening Guidelines Working Group: Endoscopy. 2012 Dec 4. PMID:23212726 Impact factor: 5.196

 

Reviews/oversiktsartikler:

8. Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer.  Br J Surg. 2013 Jan;100(1):55-65. PMID 23212620
Impact factor: 5.210

9. Sofi AA, Silverman AL, Khuder S, Garborg K, Westerink JM, Nawras A. Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scand J Gastroenterol. 2012. PMID 23163886
Impact factor: 2.329

 

Editorials/kommentarer:

10. Kalager M. First, do no harm. Tidsskr Nor Laegeforen. 2012;132:383. PMID 22353816

11. Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med. 2012;367:e31. PMID 23171121

12. Kalager M. Letter to the Editor: Hofvind S, Skaane P. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening. Fortschr Röntgenstr 2012; 184: 437-442. PMID 22851265

13. Lenz P, Domagk D, Mensink P, Aktas H, Bretthauer M. Single- versus double-balloon enteroscopy: the evidence base: Comment on Endoscopy essentials, Small-bowel endoscopy. Endoscopy. 2012 ;44:799 PMID 22833025

14. Jørgensen KJ, Kalager M, Zahl PH, Fønnebø VM. Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality. Breast Cancer Res Treat. 2012;136:617-20. PMID 23011508

15. Bretthauer M, Kalager M. Colonoscopy as a triage screening test. N Engl J Med. 2012;366:759-60. PMID 22356330

16.Bretthauer M, Hoff G. Comparative effectiveness research in cancer screening programmes. BMJ. 2012;344:e2864. PMID 22628002

17. Kalager M, Løberg M, Bretthauer M. Limited use of nonprogram screening in Norway. Int J Cancer. 2012. doi: 10.1002/ijc.27807. PMID 22933134

18. Berstad P, Løberg M, Kalager M, Jørgensen A, Garborg K, Ruud HK, Bretthauer M, Hoff G. Risk stratification for advanced colorectal neoplasia. Cancer Prev Res  2012:1405. doi: 10.1158/1940-6207.CAPR-12-0383. PMID: 23151804

19. Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, Regula J, van Leerdam M, Stefansson T, Påhlman L, Dekker E, Hernán MA, Garborg K, Hoff G. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 2012;44:695-702. PMID 22723185

 

 

Publisert 15. mai 2013 14:00 - Sist endret 27. jan. 2015 15:26